The Keck School of Medicine of USC has received $2 million from the California Institute of Regenerative Medicine (CIRM) to further augment its newly launched cGMP Laboratory, a state-of-the-art facility designed to advance early-stage research into clinically viable cell and gene therapies. To expedite the translation of these therapies from the lab to the clinic, the facility needs advanced technological know-how, streamlined operations and strict protocols for developing and testing these products, all of which the CIRM grant will help fund.
To read more, visit https://stemcell.keck.usc.edu/2-million-grant-boosts-technological-advancements-in-cutting-edge-cell-therapy-manufacturing-facility.